HARVARD BIOSCIENCE, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
HARVARD BIOSCIENCE, INC. (HBIO) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $1.56 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-11
- HARVARD BIOSCIENCE, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $383.00K, a 26.82% increase year-over-year.
- HARVARD BIOSCIENCE, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $1.18M, a 19.77% decline year-over-year.
- HARVARD BIOSCIENCE, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $797.00K.
- HARVARD BIOSCIENCE, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was -$271.00K.
- HARVARD BIOSCIENCE, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $2.30M.
- HARVARD BIOSCIENCE, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was -$1.78M.
- HARVARD BIOSCIENCE, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was -$523.00K.
- HARVARD BIOSCIENCE, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was -$1.40M, a 157.01% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $383.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $1.56M 10-Q · filed 2026-08-11 | $2.36M derived: sum of 3 quarters · filed 2026-08-11 | $2.09M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | $1.18M 10-Q · filed 2026-05-12 | $1.98M derived: sum of 2 quarters · filed 2026-05-12 | $1.71M derived: sum of 3 quarters · filed 2026-05-12 | $2.01M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | $797.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $526.00K derived: sum of 2 quarters · filed 2026-03-13 | $828.00K derived: sum of 3 quarters · filed 2026-08-11 | $2.30M 10-K · filed 2026-03-13 | ||||
| 2025-09-30 | -$271.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $31.00K derived: sum of 2 quarters · filed 2026-08-11 | $1.50M 10-Q · filed 2025-11-06 | $1.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | $302.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $1.77M 10-Q · filed 2026-08-11 | $272.00K derived: sum of 3 quarters · filed 2026-08-11 | $258.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | $1.47M 10-Q · filed 2026-05-12 | -$30.00K derived: sum of 2 quarters · filed 2026-05-12 | -$44.00K derived: sum of 3 quarters · filed 2026-05-12 | -$2.35M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | -$1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$1.52M derived: sum of 2 quarters · filed 2026-03-13 | -$3.82M derived: sum of 3 quarters · filed 2026-03-13 | -$1.78M 10-K · filed 2026-03-13 | ||||
| 2024-09-30 | -$14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$2.32M derived: sum of 2 quarters · filed 2025-11-06 | -$283.00K 10-Q · filed 2025-11-06 | -$508.00K derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | -$2.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$269.00K 10-Q · filed 2025-08-11 | $170.00K 10-Q · filed 2024-08-08 | -$494.00K derived: sum of 3 quarters · filed 2025-08-11 | -$522.00K derived: sum of 4 quarters · filed 2025-08-11 | |||
| 2024-03-31 | $2.04M 10-Q · filed 2025-05-12 | $2.47M 10-Q · filed 2024-05-07 | $1.81M derived: sum of 2 quarters · filed 2025-05-12 | $1.79M derived: sum of 3 quarters · filed 2025-05-12 | $1.67M derived: sum of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | -$225.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | -$253.00K derived: sum of 2 quarters · filed 2025-03-14 | -$373.00K derived: sum of 3 quarters · filed 2025-03-14 | -$523.00K 10-K · filed 2025-03-14 | $555.00K 10-K · filed 2024-03-07 | |||
| 2023-09-30 | -$28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$148.00K derived: sum of 2 quarters · filed 2024-11-08 | -$298.00K 10-Q · filed 2024-11-08 | $695.00K 10-Q · filed 2023-11-07 | $682.00K derived: sum of 4 quarters · filed 2024-11-08 | |||
| 2023-06-30 | -$120.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$270.00K 10-Q · filed 2024-08-08 | $710.00K derived: sum of 3 quarters · filed 2024-08-08 | -$1.23M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$150.00K 10-Q · filed 2024-05-07 | $830.00K derived: sum of 2 quarters · filed 2024-05-07 | -$1.11M derived: sum of 3 quarters · filed 2024-05-07 | -$4.28M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | $980.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$964.00K derived: sum of 2 quarters · filed 2024-03-07 | -$4.13M derived: sum of 3 quarters · filed 2024-03-07 | -$1.40M 10-K · filed 2024-03-07 | ||||
| 2022-09-30 | -$1.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$5.11M derived: sum of 2 quarters · filed 2023-11-07 | -$2.38M 10-Q · filed 2023-11-07 | -$1.83M derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | -$3.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$435.00K 10-Q · filed 2023-08-08 | $118.00K derived: sum of 3 quarters · filed 2023-08-08 | $390.00K derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | $2.73M 10-Q · filed 2023-04-26 | $3.28M derived: sum of 2 quarters · filed 2023-04-26 | $3.55M derived: sum of 3 quarters · filed 2023-04-26 | $5.43M derived: sum of 4 quarters · filed 2023-04-26 | ||||
| 2021-12-31 | $553.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $825.00K derived: sum of 2 quarters · filed 2023-03-09 | $2.70M derived: sum of 3 quarters · filed 2023-03-09 | $2.45M 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | $272.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $2.15M derived: sum of 2 quarters · filed 2022-11-09 | $1.90M 10-Q · filed 2022-11-09 | $2.81M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | $1.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.63M 10-Q · filed 2022-08-04 | $2.53M derived: sum of 3 quarters · filed 2022-08-04 | $1.20M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | -$245.00K 10-Q · filed 2022-05-04 | $660.00K derived: sum of 2 quarters · filed 2022-05-04 | -$679.00K derived: sum of 3 quarters · filed 2022-05-04 | -$1.49M derived: sum of 4 quarters · filed 2022-05-04 | ||||
| 2020-12-31 | $905.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$434.00K derived: sum of 2 quarters · filed 2022-03-11 | -$1.25M derived: sum of 3 quarters · filed 2022-03-11 | $1.49M 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | -$1.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$2.15M derived: sum of 2 quarters · filed 2021-11-05 | $586.00K 10-Q · filed 2021-11-05 | |||||
| 2020-06-30 | -$814.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $1.93M 10-Q · filed 2021-08-06 | ||||||
| 2020-03-31 | $2.74M 10-Q · filed 2021-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |